Pharmacogenetics has evolved over the past few years into pharmacogenomics, shifting focus from individual candidate genes to genome-wide association studies. The latest installment in our Genomic Medicine series, Genomics and Drug Response, reviews recent pharmacogenetic and pharmacogenomic advances, and discusses how such advances are reflected in drug labels. The authors aim to provide assurance that advances resulting from the application of genomic science to drug therapy may assist with drug selection and dosing, and reduce the odds of adverse drug reactions. Earlier articles in this series include Genomics and the Continuum of Cancer Care — NEJM, Genomics, Type 2 Diabetes, and Obesity, Ancestry and Disease in the Age of Genomic Medicine, New Therapeutic Approaches to Mendelian Disorders, Genomewide Association Studies and Assessment of the Risk of Disease, Genomic Medicine — An Updated Primer.
Posted by Karen Buckley • April 6th, 2011
Comments are closed.
Get Our Blog Updates Via E-mail!
NEJM in the News
- The New York Times/AP covered the NEJM Original Article, “Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.” The Washington Post/AP, CBS News/AP, ABC News/AP, U.S. News & World Report/AP, the Boston Herald BizSm@rt, and MedPage Today also covered the article. (August 30)
- Boston.com/GetNews referenced the 1999 NEJM Correspondence, “Hot-Tub Therapy for Type 2 Diabetes Mellitus.” Bloomberg/M2 Communications also ran the story. (August 28)
- CBS News covered the NEJM Special Article, “Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work.” Kaiser Health News covered the article as well, which was syndicated on PBS News Hour (8/26). FOX News also ran yesterday’s Reuters story on the article. (August 27)
- The Boston Globe referenced the 2012 NEJM Review Article, “Drug Therapy: Management of Opioid Analgesic Overdose,” in an article about medical marijuana’s potential to alleviate the state’s drug epidemic. (August 27)
- The Boston Globe referenced the NEJM Perspective, “Invisible Colleagues,” in yesterday’s Opinion Digest. (August 27)
- The Huffington Post referenced the NEJM Perspective, “The Next Epidemic — Lessons from Ebola,” in an article titled, “’We Were Lucky This Time': How Experts are Battling the Next Ebola.” (August 27)
NEJM on Youtube
- NEJM Group will be exhibiting at the upcoming conferences below:
- European Society of Cardiology in London, England. Aug. 29-Sept. 2. Booth #C-807
- IDWeek in San Diego, CA. Oct. 8-10. Booth #922
- American Society of Nephrology in San Diego, CA. Nov. 5-7. Booth #508
- American Heart Association in Orlando, FL. Nov. 8-10. Booth #822
- American Society of Hematology in Orlando, FL. Dec. 5-7. Booth #514
Tagsabdominal pain anemia asthma breast cancer cardiac arrest Case Records Case Records of the Massachusetts General Hospital Clinical Decisions Clinical Practice Clinical Problem-Solving colorectal cancer COPD CPR Diabetes dyspnea fever global health glucocorticoids HIV hypertension Interactive Medical Cases Massachusetts General Hospital medicine Medstro myocardial infarction NEJM nejm 200th anniversary NEJM 200th Anniversary website NEJM Group NEJM Group Open Forum New England Journal of Medicine obesity pregnancy prostate cancer Quick Take ribavirin sepsis septic shock smoking stroke thrombocytopenia tuberculosis type 2 diabetes Venous thromboembolism weight loss